MILWAUKEE – October 29, 2026 -- ManpowerGroup (NYSE: MAN) has elected Lidia Fonseca, Pfizer's former Executive Vice President and Chief Digital and Technology Officer, to its Board of Directors, effective November 1, 2026.
Fonseca built Pfizer's enterprise AI program from inception
Fonseca served as Pfizer's Chief Digital and Technology Officer from January 2019 to April 2026. She led the company's enterprise AI, digital, data and technology strategy, as well as Learning & Development and Business Process Excellence. She scaled the AI program across the enterprise, contributing to significant growth and cost savings.
She now serves as Senior Advisor to Pfizer's Chief Executive Officer and sits on the Board of Directors of Medtronic plc.
ManpowerGroup links the appointment to its transformation strategy
ManpowerGroup Chair and CEO Jonas Prising said Fonseca combines technology leadership and business transformation experience with "a clear understanding of how AI can create value at scale." Prising said her operational expertise and record of leading change strengthen the company's ability to evolve its business and advance its transformation strategy.
Fonseca spent a decade as CIO in diagnostics before Pfizer
Fonseca spent ten years in diagnostics as Senior Vice President and Chief Information Officer of Quest Diagnostics and, earlier, of LabCorp. She began her career in operations and executive leadership roles at Philips Healthcare.
She holds a bachelor's degree from the University of California, Berkeley, plus an MBA and a Master of Business Informatics from Rotterdam School of Management at Erasmus University.